Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by alnovaon Dec 27, 2018 11:23am
98 Views
Post# 29159811

Latest News

Latest NewsWell, I was wrong about News not coming out until the new year. But what I did earlier post about news of the trial starting not moving the share price up holds true. Down maybe, but not up. News from this company will need to involve $$$$$ as I have stated before. Don't get me wrong. I think it's great that the trial seems like it will finaly commence. And hopefully with good results. But with Sernova being a smaller company with $ going out and no source of revenue, it would sure be nice to see some form of association with a larger company, especially with where Sernova is at with their progress. Should Sernova get good data from the trials going forward and move to further stages of testing, they will require a good amount of funding, and hoping that the JDRF will keep them moving forward is to me just not good enough. It will take a large pharma or device company to take Sernova to any higher level than they are at now. So let's hope that all the company's talk of collaborating, partnering, or any other type of deal with a bigger player happens sooner thsn later. Good Luck To SVA in the New Year. 
Bullboard Posts